Chronicles of a Small Manufacturer Dreaming of Re-enchanting France – Episode 4: Go Live, Bioproduction, and the Revolution of Cell Therapies: France in Action!
This week, two major industrial milestones:
-Go Live at MGA! Another batch of cutting-edge industrial solutions ready to ship, pushing the boundaries of biotech, techbio, medtech, and health innovation.
-The launch of The Drug Cell (TDC), a game-changer for cell therapies in Europe! Backed by €152M under the France 2030 initiative, this new French alliance will drive scalable, AI-powered cell therapy manufacturing.
With Digital Twin technology, real-time quality control, and automated processes, TDC is set to redefine regenerative medicine in Europe. A strong partnership between leading biotech innovators, including EFS, MGA, GPI France, Carroucell, EVerZom, and top medical research centers.
In the Same Category
ENVOL Project: Maison MGA at the Heart of the “Organs-on-a-Chip” Revolution
As regulatory and ethical pressures push the industry to move away from animal testing, a major technological breakthrough is emerging in the Auvergne-Rhône-Alpes region. Maison MGA, through its subsidiary MGA MedTech, is partnering with the ENVOL project to bring the...
France2030 initiative : Breaking news
Supported by the French government as part of the France2030 initiative, in collaboration with the Secrétariat général pour l'investissement and the PIIEC Med4Cure, this program is primarily aimed at strengthening France’s health and industrial sovereignty, with a...